"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ARQT. [ FAQ on what and how to ask] For non-ARQT questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Mr. Todd Franklin Watanabe M.A.
Headquarter: 3027 Townsgate Road, Suite 300, Westlake Village, CA, United States, 91361
Industry: Biotechnology, Investment Track: Immunology & infectious diseases, Employees: 354
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
My Watchlist
